SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-399866
Filing Date
2014-11-06
Accepted
2014-11-06 08:30:58
Documents
14
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d791772d10q.htm 10-Q 655294
2 EX-10.1 d791772dex101.htm EX-10.1 8627
3 EX-12 d791772dex12.htm EX-12 24611
4 EX-31.1 d791772dex311.htm EX-31.1 8897
5 EX-31.2 d791772dex312.htm EX-31.2 8893
6 EX-32.1 d791772dex321.htm EX-32.1 3918
7 EX-32.2 d791772dex322.htm EX-32.2 3953
14 GRAPHIC g791772ex10_1logo.jpg GRAPHIC 25333
  Complete submission text file 0001193125-14-399866.txt   4520306

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alny-20140930.xml EX-101.INS 719991
9 XBRL TAXONOMY EXTENSION SCHEMA alny-20140930.xsd EX-101.SCH 35555
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20140930_cal.xml EX-101.CAL 49562
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20140930_def.xml EX-101.DEF 178163
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20140930_lab.xml EX-101.LAB 290035
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20140930_pre.xml EX-101.PRE 200990
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 141198940
SIC: 2834 Pharmaceutical Preparations